HRT and Mental Health

Educational only. Not medical advice. If you are experiencing severe depression, suicidal thoughts, or feel unsafe, call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency department. Mood changes during menopause can be serious and deserve prompt clinical attention.

The gap between gynecology and psychiatry is where menopausal women go to be undertreated. The gynecologist prescribes HRT for hot flashes and does not ask about mood. The psychiatrist prescribes an SSRI for depression and does not ask about menstrual changes. The woman sits in between, receiving incomplete care from both sides.

Menopause affects the brain directly. Estrogen receptors in the hippocampus, prefrontal cortex, and amygdala mean that hormonal changes do not just cause hot flashes - they alter mood regulation, anxiety thresholds, emotional resilience, and cognitive function. Treating these symptoms effectively requires understanding whether they are hormonally driven, whether they are primary psychiatric conditions that happen to coincide with menopause, or whether both are present simultaneously.

• Perimenopause is a high risk window for new onset depression (2 to 4x increased risk per the SWAN study), even in women with no prior psychiatric history
• Estrogen supports serotonin, norepinephrine, and dopamine function. Its loss directly affects the neurotransmitter systems that regulate mood
• HRT can be an HRT is not FDA-approved for treating depression or mood disorders. However, evidence suggests that estrogen therapy may improve mood symptoms in perimenopausal women, particularly when mood disturbance coincides with vasomotor symptoms and the menopausal transition. This is considered off-label use for hormonally driven mood changes, particularly when mood symptoms emerged alongside other menopausal symptoms
• For severe depression, suicidal ideation, or pre-existing psychiatric conditions worsening during menopause, psychiatric treatment should not be delayed while trialing HRT
• The combination of HRT plus an SSRI or SNRI often works better than either alone for women with both hormonal and primary mood components
• “Brain fog” (difficulty concentrating, word-finding problems, memory lapses) is neurobiologically real, not imagined, and typically improves with hormonal stabilization

Emerged during perimenopause or early menopause, not pre-existing. Correlate with other menopausal symptoms (vasomotor, sleep, cycle changes). Feel qualitatively different from prior mood experiences. Women often describe “this is not my normal depression/anxiety.” Fluctuate with hormonal swings rather than maintaining a steady state. Improve with sleep improvement (suggesting the mood problem is downstream of sleep disruption, which is downstream of hormonal disruption).

In these cases, HRT is a For women with clinically diagnosed depression, standard psychiatric treatment (therapy, antidepressants) should not be replaced by HRT alone, though HRT may provide adjunctive benefit when mood symptoms are clearly linked to the menopausal transition. By stabilizing hormones, resolving night sweats, improving sleep, and directly supporting neurotransmitter function, HRT addresses the upstream cause rather than treating symptoms.

Pre-existing depression or anxiety that is worsening during menopause. HRT may help as adjunct but the primary condition needs primary treatment. Severe depression with functional impairment (cannot work, cannot care for yourself, cannot maintain relationships). Suicidal ideation or self-harm. Symptoms that do not improve after 8-12 weeks of adequate HRT. Bipolar disorder, psychotic features, or other complex psychiatric presentations.

For these situations, an SSRI/SNRI, therapy (CBT, interpersonal therapy), or both should be initiated without waiting to see if HRT alone resolves the problem. HRT can be added as adjunctive treatment, and many women benefit from the combination.

This is one of the most common clinical failures in menopausal care. A 47-year-old woman presents to her primary care physician with depressed mood, anxiety, insomnia, and fatigue. Nobody asks about her menstrual cycle. Nobody asks about hot flashes. She is prescribed an SSRI. It partially helps (SSRIs have some effect on vasomotor symptoms and mood). She stays on it for years without ever being evaluated for the hormonal component.

The SSRI is not wrong. It is incomplete. For women whose depression is driven by hormonal disruption, HRT addresses the upstream cause while the SSRI treats the downstream symptom. The combination often allows lower SSRI doses or eventually SSRI discontinuation when the hormonal environment is stabilized.

If you are a woman in your 40s or 50s who was started on an antidepressant without anyone asking about menopause, it is worth discussing the hormonal dimension with a menopause-literate clinician.

Difficulty concentrating, word-finding problems, short-term memory lapses, reduced processing speed. These are objectively measurable in research settings and correlate with hormonal fluctuations. They are not early dementia, they are not “just aging,” and they are not imagined.

The mechanism: estrogen supports acetylcholine function (critical for memory), synaptic plasticity, cerebral blood flow, and brain glucose metabolism. When estrogen fluctuates wildly or declines, all of these functions are affected.

The reassurance: perimenopausal cognitive changes are generally not progressive. They are worst during the transition and tend to stabilize after menopause, particularly with HRT. If cognitive symptoms are worsening progressively rather than fluctuating, or if they include personality changes, getting lost in familiar places, or inability to perform previously routine tasks, formal neuropsychological evaluation is warranted.

The Anxiety Nobody Talks About

Depression gets the clinical attention. Anxiety during perimenopause and menopause is equally common and less discussed. For many women, new-onset anxiety - the racing heart at 3 AM, the sense of dread without cause, the inability to stop the catastrophic thinking. For many women this is more distressing than hot flashes.

The mechanism is the same: estrogen modulates GABA (the brain’s primary calming neurotransmitter) and serotonin. When estrogen fluctuates or declines, the neurochemical systems that regulate anxiety are directly affected. Women who have never had anxiety suddenly develop it. Women with manageable baseline anxiety find it escalating.

HRT can improve hormonally-driven anxiety by stabilizing the neurochemical environment. But anxiety can also become self-sustaining: once the worry patterns are established, they persist even when the hormonal trigger is addressed. Cognitive behavioral therapy (CBT) is the most effective treatment for the thought patterns that anxiety creates, and it works well alongside HRT. For severe anxiety, short-term use of buspirone or SSRIs may be appropriate. Discuss the specific options with your clinician, emphasizing that the anxiety emerged during the menopausal transition.

Long-Term Cognitive Health

The question women fear most: does menopause increase my risk of dementia? The honest answer is nuanced. Estrogen is neuroprotective. Its loss during menopause removes that protection. But “removed protection” does not automatically mean “accelerated decline.” The KEEPS and ELITE trials suggest that HRT initiated early in the menopausal transition may support cognitive health, while the WHIMS trial showed that HRT initiated after 65 in estrogen-naive women did not help and may have worsened outcomes.

The practical takeaway: the brain fog of perimenopause is not early dementia. It is hormonally driven and typically improves with treatment and time. If you have cognitive concerns, address them - but recognize that the menopausal transition itself is the most likely explanation for symptoms that emerged alongside other menopausal changes.

• Could my mood changes be related to menopause, and should we trial HRT before starting an antidepressant?
• I am already on an antidepressant - would adding HRT improve my response?
• My brain fog is significant - is this hormonal, or should we evaluate for other causes?
• At what point should I see a psychiatrist in addition to managing the hormonal component?
• How do we distinguish between hormonally driven mood changes and a primary psychiatric condition?